To visit the old Ventura website, click here.
Ventura Wealth Clients Login here

Quarterly results

rupeeShow figures in :
rupeeShow figures in :

Quarterly results

Quarter ended on June 30, 2025Data in Crores of INR
Revenue
590.51+6.33% from last year
Operating profits
74.39+12.59% from last year
Net income
53.97+62.22% from last year

Financial reports

Data is unavailable

INCOME STATEMENTinfo2
Data in Crores of INR

Data is unavailable

BALANCE SHEETinfo2
Data in Crores of INR
FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006
Net worth1281.551192.431036.36913.42652.49543.45455.43400.13357.40308.15163.16146.45123.45111.53100.1287.95
Fixed assets811.09676.23689.93665.40643.81624.86602.39581.09493.42448.46247.84208.20205.24189.94182.77183.10
Debt562.42606.52538.34344.38379.35507.21546.25479.49483.40447.90267.49188.83192.21217.15199.18189.85
docView detailed balance sheet
arrow
CASH FLOWinfo2
Data in Crores of INR
FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016FY2015FY2011FY2010FY2009FY2007
Operating358.92133.3270.41154.95250.74143.0969.77174.75133.29104.5920.5659.1264.9029.27
Investing -223.65-163.97-149.64-71.78-33.21-61.67-73.54-106.98-98.79-107.01-76.36-30.46-11.51-25.23
Financing -136.0316.5492.03-81.13-215.41-80.073.92-68.23-33.261.4652.55-23.62-53.92-5.99

Financial ratios

Profitability ratiosinfo2
ROA7.07%
ROE13.87%
ROCE15.01%
EPS18.65%
Net profit margin6.79%
Operating profit margin12.85%
Dividend per share1%
Operational ratiosinfo2
Quick ratio1.05%
Current ratio1.66%
Interest coverage7.22%
Assets turnover1.04%
Debt to equity0.44%
Valuation ratiosinfo2
P/E ratio23.68%
P/B ratio3.14%
Dividend yield0.2%
EV/EBITDA
Aarti Drugs Limited was established in the year 1984 and forms part of Aarti Group of Industries with robust RD Division at Tarapur, Maharashtra Industrial Development Corporation (MIDC) in close vicinity to manufacturing locations. The company is engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs), Pharma Intermediates, Specialty Chemicals and also produces Formulations with its wholly-owned subsidiary - Pinnacle Life Science Private Limited. Products under APIs includes Ciprofloxacin Hydrochloride, Metronidazole, Metformin HCL, Ketoconazole, Ofloxacin etc. whereas Specialty Chemicals includes Benzene Sulphonyl Chloride, Methyl Nicotinate etc.
personal

Grow your wealth with more research recommendations

+91